This activity is provided by Haymarket Medical Education (HME) for physician credit.
This activity is co-provided by Medical Education Resources (MER) for nursing contact hours.
Tamera Pearson, PhD, FNP, ACNP, associate professor, director of family nurse practitioner program, Clinical Western Carolina University, Biltmore Campus, Asheville, N.C.
Release Date: July 15, 2015
Expiration Date: July 14, 2016
Estimated time to complete the educational activity: 30 minutes
Statement of Need: Knowledge is needed in understanding the prevalence of uncontrolled blood pressure and the impact this has on the incidence of cardiovascular disease events such as stroke and myocardial infarctions. The most recently published hypertension guidelines from JNC 8 will be reviewed with an emphasis on the similarities with previous hypertension treatment recommendations.
Target Audience: This activity has been designed to meet the educational needs of primary care health care professionals who will treat patients with an uncontrolled blood pressure level.
Learning Objectives: After completing the activity, the participant should be better able to:
- Describe the connection between uncontrolled blood pressure and the pervasiveness of cardiovascular events
- Identify the similarities and differences in target blood pressure and initial treatment between the new Eighth Joint National Committee (JNC 8) guidelines and specialty organizations (American Heart Association, American College of Cardiology, and American Society of Hypertension)
Physician Credit: HME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation: HME designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit: MER is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Credit Designation: This CE activity provides 0.5 contact hour of continuing nursing education.
MER is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 0.5 contact hour.
This activity qualifies for 0.25 pharmacotherapy credit.
American Academy of Physician Assistants (AAPA)
The AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 0.5 hour of Category I credit for completing this program.
In accordance with the ACCME Standards for Commercial Support, HME requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME resolves all conflicts of interest in an effort to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Furthermore, HME seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. HME is committed to providing its learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.
The faculty reported the following financial relationships withcommercial interests whose products or services may be mentioned inthis CME/CE activity:
|Name of Faculty||Financial Relationship|
|Tamera Pearson, PhD, FNP, ACNP||No relevant financial relationships|
The planners and managers for this program reported the following financial relationships with commercial interests whose products or services may be related to the content of this CME activity:
HME planners and managers have no relevant financial relationships to disclose.
MER planners and managers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. HME and MER do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Method of Participation: There are no fees for participating in and receiving CME/CE credit for this activity. During the period of July 15, 2015, through July 14, 2016, participants must:
- Read the learning objectives and faculty disclosures;
- Study the educational activity;
- Submit the post-test online (clinicians may register at www.mycme.com);
- Complete the evaluation form online
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better.
Disclaimer: The content and views presented in this educational activityare those of the authors and do not necessarily reflect those of HME orMER. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serveas a guideline for patient management.